Related Articles
Lenvatinib as a novel treatment for anaplastic thyroid cancer: A retrospective study
Outcome of initial lenvatinib treatment in patients with unresectable anaplastic thyroid cancer
Clinical features of lenvatinib treatment in elderly patients with advanced thyroid cancer
Comparative genomic hybridization defines frequent loss on 16p in human anaplastic thyroid carcinoma.
Sorafenib in metastatic radioactive iodine‑refractory differentiated thyroid cancer: A pilot study